Compare ALLE & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALLE | PEN |
|---|---|---|
| Founded | 2013 | 2004 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.9B | 12.8B |
| IPO Year | 2013 | 2015 |
| Metric | ALLE | PEN |
|---|---|---|
| Price | $130.31 | $328.08 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 8 | 16 |
| Target Price | $167.13 | ★ $360.14 |
| AVG Volume (30 Days) | ★ 1.1M | 403.4K |
| Earning Date | 04-28-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.60% | N/A |
| EPS Growth | 9.09 | ★ 1155.56 |
| EPS | ★ 1.59 | 0.82 |
| Revenue | N/A | ★ $1,403,665,000.00 |
| Revenue This Year | $8.47 | $14.34 |
| Revenue Next Year | $4.58 | $13.71 |
| P/E Ratio | ★ $82.10 | $399.56 |
| Revenue Growth | N/A | ★ 17.50 |
| 52 Week Low | $125.00 | $221.26 |
| 52 Week High | $183.11 | $362.41 |
| Indicator | ALLE | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 41.30 | 54.47 |
| Support Level | N/A | $326.58 |
| Resistance Level | $148.87 | $335.61 |
| Average True Range (ATR) | 3.11 | 2.27 |
| MACD | 0.12 | 0.87 |
| Stochastic Oscillator | 43.74 | 81.18 |
Allegion is a global security products company with a portfolio of leading brands such as Schlage, Von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2024, Allegion generated over 75% of sales in the United States. The company primarily competes with Sweden-based Assa Abloy, Switzerland-based Dormakaba, and US-based Fortune Brands Innovations.
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.